<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A consecutive series of patients (1978-1981) comprising <z:hpo ids='HP_0000001'>all</z:hpo> patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> from a population of 475000 inhabitants was reviewed </plain></SENT>
<SENT sid="1" pm="."><plain>Thus, 94 patients were diagnosed as having <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>No patients were lost from follow-up </plain></SENT>
<SENT sid="3" pm="."><plain>The incidence figures of ALL and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> differed significantly from those of Sweden as a whole </plain></SENT>
<SENT sid="4" pm="."><plain>9 patients were less than 15 years old </plain></SENT>
<SENT sid="5" pm="."><plain>The median age of adult patients was 64 years, 60.8% being greater than or equal to 60 years old </plain></SENT>
<SENT sid="6" pm="."><plain>Of adult patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, 20% had a preleukaemic history (<z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> and others) </plain></SENT>
<SENT sid="7" pm="."><plain>None of 6 patients with <z:mpath ids='MPATH_336'>leukaemia</z:mpath> as a metamorphosis of a <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005547'>myeloproliferative disorder</z:hpo> achieved a complete remission </plain></SENT>
<SENT sid="8" pm="."><plain>The overall remission rate of the remaining adult patients was 25% </plain></SENT>
<SENT sid="9" pm="."><plain>Treated patients, 15-39 years old, with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> without any preleukaemic history, had a complete remission rate of 80% compared to 12% for patients greater than or equal to 60 years old with the same diagnosis </plain></SENT>
<SENT sid="10" pm="."><plain>Of 60 patients with 'primary' <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, 14 were not treated, mainly because of advanced age and complicating diseases </plain></SENT>
<SENT sid="11" pm="."><plain>Most of these patients died within a week of admission </plain></SENT>
</text></document>